Diabetes Pharmacy Resource Center
Once-Weekly Insulin Efsitora Non-Inferior to Daily Degludec in HbA1c Reduction for T2D
January 2, 2025
A study recently published in The New England Journal of Medicine found that once-weekly insulin efsitora alfa (efsitora) is noninferior to once-daily insulin degludec...
Low Income Associated with Increased Mortality in Young Adults with Type 2 Diabetes
January 2, 2025Low income may be linked to a significantly increased risk of all-cause mortality in younger adults...
.jpg "Combination Therapy May Improve Early Glycemic Management, Long-Term Outcomes")
Combination Therapy May Improve Early Glycemic Management, Long-Term Outcomes
January 2, 2025New insights into real-world use of combination versus step therapy may help refine early glycemic management and improve long-term outcomes...
Medtronic MiniMed 600, 700 Series Insulin Pumps Receive Class 1 FDA Recall
January 2, 2025The FDA has issued a Class I recall, the most serious type, for the Medtronic MiniMed 600 and 700 series insulin pumps, citing reduced battery life risk and unexpected insulin delivery interruptions...
Pharmacist-Led Clinics Prove Cost-Effectiveness in Management of Type 2 Diabetes
January 2, 2025Combining clinical pharmacy services and diabetes management could improve patient outcomes and lead to cost savings over time...
Studies Offer Mixed Picture of Risk of Semaglutide-Associated Suicidal Ideation Compared to Other Medications for Diabetes, Obesity
October 24, 2024Patients who take GLP-1 receptor agonists like semaglutide may be at higher risk of suicidal ideation compared with those taking other medications for diabetes and obesity...
